NewsBenzingaアプティーボは、リード候補のAPVO451についての調査新薬申請を2027年上半期に開始する予定です。 アプティーボは、リード候補のAPVO451についての調査新薬申請を2027年上半期に開始する予定です。 Benzinga 2026.09.24 12:13 (GMT+0) Open on Benzinga Other news JPMorgan Extends JPM Coin to Ethereum for Institutional Clients Nasdaq Tumbles Over 2%, Records Weekly Loss: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone Fifth Third Bancorp, Cleveland-Cliffs and 3 Stocks to Watch Heading Into Monday WGMI’s Pivot: From Bitcoin Miner To AI Power Play (Upgrade) (NASDAQ:WGMI) Weekly Market Pulse: Reality Bites (null:SPX) Exelon: Shelter From The Storm And Nice Yield As Utilities Catch A Bid (NASDAQ:EXC)
Nasdaq Tumbles Over 2%, Records Weekly Loss: Investor Sentiment Weakens, Fear & Greed Index Moves to ‘Extreme Fear’ Zone
